AdvertisementPeruvian federal prosecutors and a congressional commission are investigating how the Sinopharm shots ended up allocated to a privileged few as COVID-19 ravaged the country of 32 million. The Chinese shots have had to overcome considerable initial public skepticism compared with heavily hyped Western competitors such as the one from U.S.-based Pfizer and Germany-based BioNTech. AdvertisementBesides being cheaper than U.S.-made vaccines, the Chinese shots have other advantages. Astete resigned as foreign minister Saturday after admitting to what she called the “grave mistake” of being inoculated with the Chinese vaccine before its public release. It turned out, the current president said, that 487 people were “irregularly” given the Sinopharm vaccine.

Source: Los Angeles Times February 19, 2021 01:53 UTC